Choosing oral treatment does not eliminate the need for an individualized, supervised dosing plan
Clinical trials for GLP-1 agonists have reported musculoskeletal side effects such as back pain and muscle pain in a small percentage of participants, but joint pain specifically has not emerged as a consistent or significant adverse event across the class
Standard coagulation tests like PT, APTT, and INR remained unchanged, suggesting the anti-clotting effect works through platelet function rather than the coagulation cascade
Most patients are able to continue treatment
Without good sleep, these chemicals push you to eat more
Side-effect patterns and tolerability Both medicines can cause similar early symptoms such as nausea, mild bloating, or reduced appetite